Adverse events of treatment with rituximab in patients with myositis
Rheumatology (Oxford)
.
2023 Feb 1;62(2):e16-e17.
doi: 10.1093/rheumatology/keac398.
Authors
Sergio Gilaberte
1
,
Joana Rua
2
,
David Isenberg
2
3
Affiliations
1
Internal Medicine Department, Hospital Universitario de Guadalajara, Guadalajara, Spain.
2
Department of Internal Medicine, Centro Hospitalar de Tras-os-Montes e Alto Douro, Vila Real, Portugal.
3
Centre for Rheumatology, University College London Hospital, London, UK.
PMID:
35809059
DOI:
10.1093/rheumatology/keac398
No abstract available
Publication types
Letter
MeSH terms
Antirheumatic Agents* / adverse effects
Humans
Myositis* / chemically induced
Myositis* / drug therapy
Rituximab / adverse effects
Treatment Outcome
Substances
Rituximab
Antirheumatic Agents